Survey is now closed. We had an awesome response - thanks for your support! Orion Pharma, a pharmaceutical company based in Finland, would like to gather information about Raynaud’s from people suffering from this condition. The data gathered in the research will be used by Orion to help develop a new class of medication for Raynaud's patients.
The Scleroderma Foundation/Tri-State Chapter is holding an upcoming fundraising event in New York City: Stepping Out to Cure Scleroderma Manhattan Walk Location: Battery Park Date: Sunday, June 12th Registration: 9:00AM Walk: 10:15AM For further walk or volunteer information call the Scleroderma Foundation/Tri-State, Inc. Chapter office at 800-867-0885 or email sdtristate@scleroderma.org.
Bubble Wrap® sponsors an annual contest that challenges students nationwide in grades six through eight to demonstrate their creativity and ingenuity by designing an invention that incorporates the use of Bubble Wrap® brand cushioning. The children compete to win $25,000 in prizes and savings bonds. One of this year's finalists invented a way to use Bubble Wrap® to
Drug Intended for the Treatment of Raynaud's Phenomena, Secondary to Systemic Sclerosis SAN DIEGO, April 13, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) announced today its filing with the U.S. Food & Drug Administration ("FDA") requesting orphan drug designation for RayVa™, the Company's drug candidate indicated for the treatment of Raynaud's
We’ve heard from a manufacturer who has been developing a heated steering wheel cover and it’s great news: The prototype is ready and it’s “everything we wanted it to be!” We’ll be seeing the prototype later this month, and if all goes well, the product may be available for purchase in time for next fall. In